clients served
…for biopharma and device companies that want a creative approach to putting a human face on a complex need.
…to tell their stories in the most purposeful way so their input is equally if not more valuable than data and stats.
…in plain language so that patients and those who care for them understand their impact on access to care and potential for good health.
… with ideas and pathways to achieve measurable improvements in the development of a care.
Part lawyer, part clinician, long time Washington-insider, Gwen is a seasoned thought leader and creative magnet who brings decades of expertise to the discussion with one aim in mind: ensuring patients are heard and their input is valued.
A storyteller at heart, Gwen helps biopharma companies and advocates tell a better story — one that captures the essence of what it means to improve or save a life.
Gwen has a unique ability to navigate complex organizations -- understands the passion of advocates and helps them make their strongest case for support in many ways. She is candid, responsive and creative in her approaches to policy and philanthropy. It was a pleasure to work with Gwen when she was the "hub" for Planned Parenthood's relationship with Bayer. Her hands-on and "roll the sleeves up" approach to the work together made every interaction productive and meaningful.
Gwen brings a unique perspective to the advocacy relations team from her career-long accomplishments in public policy and regulatory affairs. She is committed to finding ways to elevate the patient's voice in public policy and bringing energy and respect to the patient's experience in all that Bayer does for patients.
I have had the great pleasure to know Gwen Mayes as our paths have crossed in women's health advocacy for the past few years. She is smart, articulate and generous with those who seek her counsel and much sought after guidance. Her extensive healthcare background gives her a unique perspective and knowledge base when it comes to seeking guidance with federal regulators and thought leaders in Washington DC. She is respected by her colleagues and business associates, and her sense of humor is superb. Lucky are those who are able to learn from her, work with her, and enjoy her keen mind and sharp wit.
One of the most surprising conversations I had while working in industry came when a colleague of mine in the regulatory department called to get my input on the value of patient engagement to the company. He was drafting a response to FDA’s proposed ombudsmen-type “patient office” and new requirements to include patient experiences in […]
During a meeting with the American College of Not-to-be-Named-Doctors, their staff shared with me that the Incoming President’s plan was for it to be “the year of the patient.” Immediately, I wondered why it wasn’t every year. Clearly the mission of any professional medical society is to be a voice for its members, but their […]